Long intergenic non-protein coding RNA 2821 (LINC02821)

Long intergenic non-protein coding RNA 2821 (LINC02821) is a member of the long intergenic non-coding RNA (lincRNA) family, which are RNA transcripts longer than 200 nucleotides located in genomic regions that do not overlap any protein-coding genes[3][1]. LINC02821 itself is annotated in human genomic reference sets, but there is no published functional or clinical data, and it is not recognized as a validated molecular target for therapy, nor as a biomarker for disease. In general, lincRNAs fine-tune gene expression—often in a tissue-specific manner—through actions such as remodeling chromatin, regulating transcription, or acting as protein/RNA scaffolds[3]; however, there is currently no evidence directly supporting any specific biological or disease role for LINC02821. There are also no known drugs, therapeutic mechanisms, or patient selection biomarkers related to LINC02821. The designation "non-protein coding" and lack of literature support for a target, receptor, or enzyme function mean LINC02821 is *not* considered a therapeutic target and, given the absence of specific function or disease association, its identification as a distinct target may be incorrect in most drug discovery contexts. Key points supporting "is incorrect: true": - There is no evidence that LINC02821 is a validated molecular target (receptor, enzyme, transporter, etc.) in scientific or medical literature. - No function, disease association, or relevance as a target is identified for this molecule based on current knowledge. - It may be misidentified as a true therapeutic target due to lack of functional evidence. Additional notes: Information specific to LINC02821 is not available beyond gene annotation databases. Most knowledge about lincRNAs is generalized and does not pertain to this particular locus[3][1][5]. If you meant a different gene or molecule, or if LINC02821 is a recently discovered entity, further context or additional identifiers may be needed.

Not established for LINC02821.